GOVX vs NCLH · $10.6M cap vs P/E 16, rev $4.97B
GeoVax Labs Inc (GOVX) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
GeoVax Labs Inc (GOVX) is a biotechnology company listed on US.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported GOVX revenue for 2026-06-30 was $0. Net income was -$9.7M. GOVX currently screens at market cap $10.6M.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
GOVX currently screens at market cap $10.6M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the GOVX and NCLH stock pages for the full models.
Not investment advice.